Serial Number | 90022437 |
Word Mark | IMGT IMAGE GUIDED THERAPY |
Filing Date | Friday, June 26, 2020 |
Status | 700 - REGISTERED |
Status Date | Tuesday, November 2, 2021 |
Registration Number | 6542241 |
Registration Date | Tuesday, November 2, 2021 |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, August 17, 2021 |
Indication of Colors claimed | The color(s) blue and light blue is/are claimed as a feature of the mark. |
Disclaimer with Predetermined Text | "IMAGE GUIDED THERAPY" |
Description of Mark | The mark consists of a bent molecule feature composed of a larger light blue orb with blue shading connected with two smaller light blue orbs with blue shading, next to the stylized wording of "IMGT" in blue, over the stylized wording of "IMage Guided Therapy" where the letters, "IM" are in blue, "age" are in light blue, "G" are in blue, "uided" are in light blue, "T" are in blue, and "herapy" are in light blue. |
Goods and Services | Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting peripheral nervous system; Enzymes for medical purposes; Pharmaceutical preparations acting on the central nervous system; Antibiotic preparations; Chemotherapeutics; Veterinary vaccines; Vaccines; Chemical reagents for medical or veterinary purposes; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of CNS disorders; Pharmaceutical preparations for the treatment of peripheral vascular or neurologic disease; Pharmaceutical preparations for the treatment of lesions; Pharmaceutical preparations for reliving pain; Pharmaceutical preparations for activating drug delivery; Nutraceuticals for use as a dietary supplement for promoting digestion; Anti-cancer preparations |
Goods and Services | Medical apparatus, namely, medical ultrasound apparatus; Medical apparatus, namely, ultrasound diagnostic apparatus; Medical instruments for use in general surgery; Medical apparatus for treating cancer; Medical apparatus for treating cancer by using ultrasound; Medical apparatus for treating CNS disorders; Medical apparatus for treating CNS disorders by using ultrasound; Medical apparatus for treating peripheral vascular or neurologic disease; Medical apparatus for treating peripheral vascular or neurologic disease by using ultrasound; Medical apparatus for treating dermatological disease by using ultrasound; Medical apparatus for treating dermatological disease; Medical apparatus for treatment of lesions; Medical apparatus for treatment of lesions through hyperthermia caused by using ultrasound; Medical apparatus for relieving pain; Medical apparatus for relieving pain by using ultrasound; Medical apparatus for activating drug delivery; Medical apparatus for activating drug delivery by using ultrasound; Syringes for medical purposes and for injections; Medical apparatus for detecting cancer; Dental instruments, namely, picks, burrs, mirrors, prophy angles, oral irrigators, crown and bridge removers; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Diagnostic apparatus for the detection of periodontal disease; Diagnostic apparatus for the detection of cancer; Medical diagnostic apparatus for detecting cancer; Injection device for pharmaceuticals; Syringes for medical purposes; Syringes for injection of medical substances; Hypodermic syringes |
Goods and Services | Drug discovery services; Biotechnology research; Biomedical research services; Laboratory research in the field of biology; Providing information on the subject of scientific research in the field of Biochemistry and biotechnology; Biological research; Bacteriological research; Pharmaceutical research and development; Research on the subject of pharmaceuticals; Clinical research in the field of medicines for detection and treatment of cancer; Conducting clinical trials for others in the field of medicines for detection and treatment of cancer; Medical research services; Scientific research for medical purposes in the field of cancer; Testing of pharmaceuticals; Testing of materials; Chemical research and analysis; Chemical research services |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, July 23, 2020 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, July 23, 2020 |
Primary Code | 010 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, July 23, 2020 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | IMGT Co., Ltd. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | Gyeonggido 13605 KR |
Party Name | IMGT Co., Ltd. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Gyeonggido 13605 KR |
Party Name | IMGT Co., Ltd. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Gyeonggido 13605 KR |
Event Date | Event Description |
Tuesday, November 2, 2021 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, August 17, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, August 17, 2021 | PUBLISHED FOR OPPOSITION |
Wednesday, July 28, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Monday, July 12, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, June 15, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, June 15, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, June 7, 2021 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Monday, March 22, 2021 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Monday, March 22, 2021 | LETTER OF SUSPENSION E-MAILED |
Monday, March 22, 2021 | SUSPENSION LETTER WRITTEN |
Friday, March 19, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, March 19, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, March 19, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, October 2, 2020 | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED |
Friday, October 2, 2020 | ASSIGNED TO LIE |
Friday, October 2, 2020 | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
Friday, October 2, 2020 | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
Friday, October 2, 2020 | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED |
Tuesday, September 29, 2020 | ASSIGNED TO EXAMINER |
Friday, July 24, 2020 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Thursday, July 23, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Tuesday, June 30, 2020 | NEW APPLICATION ENTERED IN TRAM |